Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1375 of 1863 entries
View as:

Adaptation of Skills Training Manuals for Patients Receiving Hematopoietic Stem Cell Transplantation and Their Caregivers

Phase: N/A Priority: Normal
NCT ID: NCT02928185 Org: User:
Start: 09/30/16 End: 09/30/25 Due: 09/30/26

Supervised Aerobic Training During or After Chemotherapy for Operable Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01943695 Org: User:
Start: 01/31/13 End: 08/31/25 Due: 08/31/26

Physician Use of Non-English Language Skills in Cancer Care

Phase: N/A Priority: Normal
NCT ID: NCT02726360 Org: User:
Start: 12/14/15 End: 08/21/23 Due: 08/21/24

A Randomized Study of the Efficacy of Low Venous Pressure General Anesthesia Versus Combined Spinal-Epidural Anesthesia in Decreasing Blood Loss During Prostate Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00200187 Org: User:
Start: 02/28/05 End: 01/31/07 Due: 01/31/08

Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation

Phase: N/A Priority: Normal
NCT ID: NCT04854005 Org: User:
Start: 04/20/21 End: 04/30/26 Due: 04/30/27

Placebo Controlled Trial of SOM230 for the Reduction of Post-Pancreatectomy Fistula, Leak, and Abscess

Phase: N/A Priority: Normal
NCT ID: NCT00994110 Org: User:
Start: 10/31/09 End: 09/30/14 Due: 09/30/15

ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00016172 Org: User:
Start: 11/30/00 End: 04/30/02 Due: 04/30/03

Lenalidomide Maintenance in Plasma Cell Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT02538198 Org: User:
Start: 08/31/15 End: 08/31/25 Due: 08/31/26

A Study of Changes to Prostate Procedures

Phase: N/A Priority: Normal
NCT ID: NCT06986083 Org: User:
Start: 05/19/25 End: 05/31/28 Due: 05/31/29

Propofol's Hypnotic and Memory Effects

Phase: N/A Priority: Normal
NCT ID: NCT00576615 Org: User:
Start: 05/31/02 End: 05/31/16 Due: 05/31/17

Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00004059 Org: User:
Start: 07/31/99 End: 09/30/02 Due: 09/30/03

Developing a New Questionnaire About Patient Expectations of Breast Conserving Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02753673 Org: User:
Start: 04/20/16 End: 04/13/20 Due: 04/13/21

Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ

Phase: N/A Priority: Normal
NCT ID: NCT00581750 Org: User:
Start: 10/31/01 End: 06/28/21 Due: 06/28/22

Registry for Patients With Acquired Resistance to Small Molecule Kinase Inhibitors in Non-Small-Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00579683 Org: User:
Start: 08/31/04 End: 02/29/16 Due: 02/28/17

Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas

Phase: N/A Priority: Normal
NCT ID: NCT00003923 Org: User:
Start: 03/31/99 End: 02/28/02 Due: 02/28/03

HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01119066 Org: User:
Start: 05/03/10 End: 03/30/21 Due: 03/30/22

Combination Chemotherapy and Surgery in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00003776 Org: User:
Start: 12/31/98 End: 03/31/00 Due: 03/31/01

Anti-GD2 3F8 Monoclonal Antibody and GM-CSF for High-Risk Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT02100930 Org: User:
Start: 03/31/14 End: 03/07/19 Due: 03/07/20

Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00037011 Org: User:
Start: 11/30/01 End: - Due: -

Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00004215 Org: User:
Start: 08/31/99 End: 08/31/00 Due: 08/31/01

Acupuncture for the Treatment of Chronic Post-Chemotherapy Fatigue: A Randomized, Phase III Trial

Phase: N/A Priority: Normal
NCT ID: NCT00200096 Org: User:
Start: 07/31/04 End: 02/28/11 Due: 02/28/12

A Study Comparing Two Types of Supportive Interventions for Caregivers of Patients With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04802720 Org: User:
Start: 02/26/21 End: 01/08/26 Due: 01/08/27

Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed or Refractory Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00255723 Org: User:
Start: 04/30/04 End: 07/31/12 Due: 07/31/13

Erlotinib and Chemotherapy for Patients With Stage IB-IIIA NSCLC With EGFR Mutations (ECON)

Phase: N/A Priority: Normal
NCT ID: NCT00577707 Org: User:
Start: 11/30/07 End: 12/31/11 Due: 12/31/12

Treatment of Tumors in the Urinary Collecting System of the Kidney or Ureter Using a Light Activated Drug (WST11)

Phase: N/A Priority: Normal
NCT ID: NCT03617003 Org: User:
Start: 08/01/18 End: 12/02/25 Due: 12/02/26